NASA NTRS · 20210002702
The Space Interferometry Mission (SIM) is a space-based 10 m baseline Michelson interferometer.
Explore connections, maps & timelines
Aaron, K.. 1999-03-06. SIM Configuration Evolution. https://ntrs.nasa.gov/citations/20210002702
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Astronauts are known to exhibit a variety of immunological alterations during spaceflight including changes in leukocyte distribution and plasma cytokine concentrations, a reduction in T-cell function, and subclinical reactivation of latent herpesviruses. These alterations are most likely due to mission-associated stressors including circadian misalignment, microgravity, isolation, altered nutrition, and increased exposure to cosmic radiation. Some of these stressors may also occur in terrestrial situations. This study sought to determine if crewmembers performing overwinter deployment at Palmer Station, Antarctica displayed similar immune alterations. The larger goal was to validate a ground analog suitable for the evaluation of countermeasures designed to protect astronauts during future deep space missions. For this pilot study, plasma, saliva, hair, and health surveys were collected from Palmer Station, Antarctica winterover participants at baseline, and at five overwinter timepoints. Twenty-six subjects consented to participate over the course of two seasons. Initial sample processing was performed at Palmer, and eventually stabilized samples were returned to the Johnson Space Center for analysis. A white blood cell differential was performed (real time) using a fingerstick blood sample to determine alterations in basic leukocyte subsets throughout the winterover. Plasma and saliva samples were analyzed for 30 and 13 cytokines, respectively. Saliva was analyzed for cortisol concentration and three latent herpesviruses (DNA by qPCR), EBV, HSV1, and VZV. Hair samples were analyzed for several hormones, as a measure of stress over prolonged periods of time. Voluntary surveys related to general health and adverse clinical events were distributed to participants. It is noteworthy that due to logistical constraints due to COVID-19, the baseline samples for each season were collected in Punta Arenas, Chile, after long international travel and during isolation. Therefore, the palmer pre mission samples may not reflect a true normal ‘baseline’. Minimal alterations were observed in leukocyte distribution during overwinter. The mean percentage of monocyte concentration elevated at one timepoint. Plasma G-CSF, IL1RA, MCP-1, MIP-1β, TNFα and VEGF were decreased during at least one overwinter timepoint, whereas RANTES was significantly increased. No statistically significant changes were observed in mean saliva cytokine concentrations. Salivary cortisol was substantially elevated throughout the entire winterover compared to baseline. Compared to shedding levels observed in healthy controls (23%), the percentage of participants who shed EBV was higher throughout all winterover timepoints (52-60%). Five subjects shed HSV1 during at least one timepoint throughout the season compared to no subjects shedding during pre-deployment. Finally, VZV reactivation, common in astronauts but exceptionally rare in ground-based stress analogs, was observed in one subject during pre-deployment and a different subject at WO2 and WO3. These pilot data, somewhat influenced by the COVID-19 situation, do suggest that participants at Palmer Station do undergo immunological alterations similar to, but likely in reduced magnitude, as those observed in astronauts. We suggest that overwinter at Palmer Station may be suitable test analog for spaceflight biomedical countermeasures designed to mitigate clinical risks for deep space missions.
Propulsion subsystem surge analysis and testing was performed at NASA Goddard Space Flight Center (GSFC) in order to analytically and experimentally determine the potential for damaging dynamic pressure events in the Plankton Aerosol Cloud and ocean Ecosystem (PACE) propulsion subsystem. Surge pressures occur when propellant flow is initiated following the actuation of an isolation valve separating an upstream high pressure fluid from a downstream low pressure manifold. By design, the PACE propulsion subsystem mitigates surge pressures using an orifice, or a cavitating venturi, placed upstream of each thruster bank isolation latch valve. Venturi sizing is a balancing act due to the competing performance goals of staying within the margins of an acceptable pressure loss and maintaining surge pressures below the proof pressure rating of the subsystem components. Subsystem pressure loss is dependent upon the venturi throat diameter and is higher for smaller venturi sizes. A venturi with a smaller throat diameter incurs an increased pressure loss through the orifice resulting in a reduced thruster inlet pressure and diminished thruster performance. The PACE propulsion subsystem surge analysis and testing supports system optimization, i.e. pressure drop minimization, while still meeting the surge pressure requirements to maximize overall system performance. In this paper a new approach to surge pressure analytical gauging is discussed, as well as its accuracy when compared to traditional surge testing campaign.
Reducing nonrecurring cost and shortening the build schedule for space qualified avionics has been a recurring theme in Space Industry. The NASA Goddard Space Flight Center has leverage its heritage flight qualified design and developed a portfolio of modular avionics comprised of 22 different board designs in a form factor named MUSTANG (Modular Unified Space Technology Avionics for Next Generation) that can be utilized in a variety flight applications. Since the design has no backplane, the modules can be mixed and match to meet the needed requirements. The MUSTANG form factor is sized to fill the void between 3U and 6U form factor and with flexibility to adapting the design without relaying out the boards.